In vivo metal-catalyzed SeCT therapy by a proapoptotic peptide.
In vivo metal-catalyzed SeCT therapy by a proapoptotic peptide.
复制标题
DOI:
10.1039/d1sc01784e
复制
发表时间:
2021-09-29
期刊:
影响因子:
8.4
通讯作者:
Tanaka K
中科院分区:
文献类型:
--
作者:
Ahmadi P;Muguruma K;Chang TC;Tamura S;Tsubokura K;Egawa Y;Suzuki T;Dohmae N;Nakao Y;Tanaka K
Selective cell tagging (SeCT) therapy is a strategy for labeling a targeted cell with certain chemical moieties via a catalytic chemical transformation in order to elicit a therapeutic effect. Herein, we report a cancer therapy based on targeted cell surface tagging with proapoptotic peptides (Ac-GGKLFG-X; X = reactive group) that induce apoptosis when attached to the cell surface. Using either Au-catalyzed amidation or Ru-catalyzed alkylation, these proapoptotic peptides showed excellent therapeutic effects both in vitro and in vivo. In particular, co-treatment with proapoptotic peptide and the carrier–Ru complex significantly and synergistically inhibited tumor growth and prolonged survival rate of tumor-bearing mice after only a single injection. This is the first report of Ru catalyst application in vivo, and this approach could be used in SeCT for cancer therapy. The combination of a proapoptotic peptide with covalent tagging and a carrier-Ru-complex inhibited tumor growth in mice after a single injection.
登录
查看更多内容
影响因子:
8.4
作者:
Kamo N;Kujirai T;Kurumizaka H;Murakami H;Hayashi G;Okamoto A
通讯作者:
Okamoto A
影响因子:
8.4
作者:
Heinisch T;Schwizer F;Garabedian B;Csibra E;Jeschek M;Vallapurackal J;Pinheiro VB;Marlière P;Panke S;Ward TR
通讯作者:
Ward TR
影响因子:
3.8
作者:
Contreras, JL;Xie, D;Eckhoff, DE
通讯作者:
Eckhoff, DE
影响因子:
2.2
作者:
KIM, SA;PEACOCK, JS
通讯作者:
PEACOCK, JS
影响因子:
5.6
作者:
Ghuman, J;Zunszain, PA;Curry, S
通讯作者:
Curry, S